GKB Ophthalmics share news and announcements
NSE: GKBBSE: 533212Healthcare Equipment & SuppliesSmall Cap
Last close ₹59.54up ₹0.93 (1.59%)BSE ₹64.97
Share price at the NSE close on 23 Oct 2026. Previous close ₹58.61.
52-week range of BSE trades to 23 Oct 2026
₹45.25Low, 5 Dec 2025₹76.90High, 15 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹30 Cr3,821st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 12 Aug 2026
- 9.3
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 6.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 0.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- 6.2%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- 10.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.21
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,45587.1% delivered
GKB Ophthalmics share news and announcements
995 announcements, routine notices left out, newest first. Page 18 of 20.
Apr 2012
Mar 2012
Feb 2012
14 Feb · Management
Board of Directors of the company in its meeting held on February 13, 2012, inter alia, has passed a resolution for re-appointment of Mr. K. G.Gupta as Managing Director of the Company for a period of 3 years effective from April 01, 2012. (Source MSE)14 Feb · Management
Reappointment14 Feb · Board meeting
Board of Directors of the Company at its meeting held on February 13, 2012, inter alia, has passed a resolution for re-appointment of Mr. K. ....13 Feb · Limited Review for Dec 31, 2011
Jan 2012
25 Jan · Board meeting
Inter alia, to consider and take on record the Un-audited Financial Results of the company for the quarter ended December 31, 2011. (Source MSE)
Dec 2011
29 Dec · Meeting
Members at the 29th Annual General Meeting (AGM) of the Company held on December 29, 2011, inter alia, have approved the following: 1. ....
Nov 2011
16 Nov · Board meeting
Board, at its meeting held on 14th November 2011, approved the draft notice for holding of the Annual General Meeting on 29th December 2011. (Source MSE)16 Nov · Meeting
Outcome of Board Meeting16 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 14, 2011, has approved the draft notice for holding of the Annual General ....4 Nov · Meeting
Outcome of Board Meeting of the Company held on November 02, 2011, as follows: (1) To make an application to the Registrar of Companies, Goa, Daman & Diu, seeking further extension of time for holding the Annual General Meeting by December 30, 2011 (2) Consequently, the Annual General Meeting of the Company scheduled on November 14, 2011 stands postponed. (Source MSE)4 Nov · Board meeting
Annual General Meeting Postponed4 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 02, 2011, has transacted the following: 1. To make an application ....
Oct 2011